Phio Pharmaceuticals Corp. (PHIO) Tops Q3 EPS by 260c

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q3 EPS of ($1.54), $2.60 better than the analyst estimate of ($4.14).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• HSBC Upgrades YPF S.A. (YPF) to Buy
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral